These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24627270)

  • 1. Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression.
    Dews M; Tan GS; Hultine S; Raman P; Choi J; Duperret EK; Lawler J; Bass A; Thomas-Tikhonenko A
    J Natl Cancer Inst; 2014 Apr; 106(4):dju043. PubMed ID: 24627270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
    Lee CW; Ito K; Ito Y
    Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors.
    Dews M; Fox JL; Hultine S; Sundaram P; Wang W; Liu YY; Furth E; Enders GH; El-Deiry W; Schelter JM; Cleary MA; Thomas-Tikhonenko A
    Cancer Res; 2010 Oct; 70(20):8233-46. PubMed ID: 20940405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation.
    Berger DH; Feng XH; Yao J; Saha D; Beauchamp RD; Lin X
    Surgery; 2002 Aug; 132(2):310-6. PubMed ID: 12219028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
    Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer.
    Deng X; Cao Y; Liu Y; Li F; Sambandam K; Rajaraman S; Perkins AS; Fields AP; Hellmich MR; Townsend CM; Thompson EA; Ko TC
    Mol Carcinog; 2013 Apr; 52(4):255-264. PubMed ID: 22161860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.
    Fleming NI; Jorissen RN; Mouradov D; Christie M; Sakthianandeswaren A; Palmieri M; Day F; Li S; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Zhu HJ; Mariadason JM; Burgess AW; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Cancer Res; 2013 Jan; 73(2):725-35. PubMed ID: 23139211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.
    Itatani Y; Kawada K; Sakai Y
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma.
    Sokolova V; Fiorino A; Zoni E; Crippa E; Reid JF; Gariboldi M; Pierotti MA
    J Cell Physiol; 2015 Dec; 230(12):3105-14. PubMed ID: 26012475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
    Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
    Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
    Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
    Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
    J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
    Hu W; Wu W; Nash MA; Freedman RS; Kavanagh JJ; Verschraegen CF
    Anticancer Res; 2000; 20(2A):729-33. PubMed ID: 10810347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-β-dependent mechanisms.
    Shi X; Mihaylova VT; Kuruvilla L; Chen F; Viviano S; Baldassarre M; Sperandio D; Martinez R; Yue P; Bates JG; Breckenridge DG; Schlessinger J; Turk BE; Calderwood DA
    Proc Natl Acad Sci U S A; 2016 Aug; 113(31):E4558-66. PubMed ID: 27432991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of TGF-β signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer.
    Sharma V; Antonacopoulou AG; Tanaka S; Panoutsopoulos AA; Bravou V; Kalofonos HP; Episkopou V
    Cancer Res; 2011 Oct; 71(20):6438-49. PubMed ID: 21998011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.